Case Study: How THEIA’s Risk Quotient (RQ) Spots Risks the Market Missed — Northern Trust & Comerica

Nasdaq: NTRS / NYSE: CMA

We put Northern Trust (NTRS) and Comerica (CMA) to the test with THEIA’s Risk Quotient (RQ). By mapping company risk scores against stock prices and the industry benchmark, we show where disclosed risks were priced — and where they were ignored. For investors and risk managers (and their fiduciaries), these insights highlight mispriced risk before it becomes obvious.

Executive Summary

Forward-looking analysis highlights where public appreciation of disclosed risks remains incomplete. These under-appreciated risks create opportunities for investment portfolio calibration, as well as for risk fiduciaries to strengthen disclosure, planning, and mitigation. THEIA’s RQ illuminates the gap between what has been disclosed and what the market has absorbed.

In this case, both companies sit below their industry average RQ, but for different reasons: NTRS due to structural non-credit sensitivities to rates/funding/regulation, and CMA due to cyclical credit and funding dynamics, including integration history and recent activist-driven execution risk. The stock-price overlay helps distinguish what is already priced from what remains under-appreciated, and highlights where forward-looking risk could still affect the companies’ performance.

Northern Trust (NTRS)

Northern Trust (NTRS): Stock Price & Risk Quotient Overlay

NTRS’s RQ has generally been worse than the industry average, consistent with disclosures focused on non-credit drivers: fee waivers in low-rate regimes, deposit mix/costs, liquidity management, and regulatory requirements.

Two Multi-year Patterns Are Key

1. 2012–2015 RQ Deterioration:
   The RQ deteriorated as zero-rates and fee waivers hit earnings — a risk Northern Trust disclosed clearly. The market recognized it, as stock softness matched the risk signal. Disclosures emphasize the dependence of certain fee lines on short-term rates and cash balances, as well as balance-sheet margin pressure. These factors explain a worse RQ relative to the industry during those years.

2. 2021 RQ Floor and Subsequent Rise/Choppiness (less risk, then mixed):
   The RQ reached its local low around 2021 amid peak pandemic-era rate suppression and waivers. With 2022 rate hikes, waivers rolled off and the RQ improved. In 2023, sector-wide funding stress and the FDIC special assessment drove the RQ back down (more risk). Through 2024–2025, choppiness reflects the tension between improved rate tailwinds and ongoing deposit cost/competition and regulatory items.

Risk Analysis

RQ vs. Industry Average: Narrative

The below-industry positioning is most pronounced in extended low-rate periods (2012–2015; 2020–2021), then narrows as rates rise (2022) and waivers roll off. The 2023 re-widening aligns with funding costs and FDIC charges. Overall, the gap reflects structural non-credit sensitivities vs. a diversified Financials composite.

Comerica (CMA): Stock Price & Risk Quotient Overlay

CMA’s RQ hit its cycle low in 2013 and has generally improved since then (higher RQ = lower risk), with discrete periods where risk worsened: a modest deterioration in 2019, a COVID/CECL deterioration in 2020, and funding-stress deterioration in 2023–early 2024. From a local low in 2024, the RQ improved into 2025 and is flat to slightly rising most recently. Since 2024, the stock and RQ have moved largely in parallel, suggesting the market has been absorbing disclosed risks in this latest phase.

Two Multi-year Patterns Are Key

1. 2013 Trough Followed by a Long-Run Improvement (less risk):

2. Early-2024 Local Low, Then Improvement and 2025 Plateau (risks appreciated):
   The RQ deteriorated again into early/mid-2024, then improved and has been flat to slightly rising into 2025. Over this window, the stock and RQ lines move roughly in parallel (no meaningful divergence), consistent with appreciated risk in this schema.

Risk Analysis

Appreciated Risks
(no divergence; RQ change aligns with stock move)

• 2019 dip: RQ deteriorated with contemporaneous stock softness.
• 2024–2025 recovery: RQ improved from the 2024 local low and the stock rose in parallel.

Explicit but Under-Appreciated Risks (divergence)

• 2011–2013 integration/credit normalization: RQ deteriorated to the 2013 trough while the stock was rising → under-appreciated by definition (disclosed risk reflected in RQ but not in price).
• 2022-2024 mixed RQ rising, stock falling, warrants a closer look.

Looming Risks (disclosed, not yet realized)

• CRE refinancing wall (2024–2026), duration/AOCI sensitivity, funding-mix/capital constraints, and activist execution risk would be under-appreciated only if the RQ deteriorates without a corresponding stock de-rating. The recent data do not show a persistent divergence.
• CRE rollover timing (maturities disclosed but not yet biting).
• Potential M&A/mark-to-market and integration execution.
• Execution outcomes on activist cost programs (could improve RQ if successful; could worsen RQ if disruptive).

RQ vs. Industry Average: Narrative

CMA’s RQ remains below the Financials industry average, but since the 2013 trough the direction is up, interrupted by discrete setbacks in 2019, 2020, and 2023–2024. From the 2024 local low, the RQ has improved and then leveled off into 2025, while the stock recovered in step—indicating that, in the recent period, disclosed risks are appreciated rather than ignored.

These case studies prove it: THEIA’s RQ doesn’t just track risk — it shows when the market is asleep at the wheel. For investors and leaders, that edge is the difference between reacting late and positioning early.

Framework for Risk Interpretation:

Appreciated Risks (No Divergence)
A disclosed risk is reflected in the RQ (e.g., RQ deteriorates) and the stock moves in the expected direction (e.g., de-rates). Market has absorbed or “appreciated” the risk.

Explicit But Under-Appreciated Risk (Divergence)
A disclosed risk is reflected in the RQ (e.g., RQ deteriorates) but the stock does not move as expected or moves opposite (flat/up). That divergence signals the market may not have fully priced the risk.

Looming Risks (Disclosed, Not Yet Realized)
A disclosed, contingent risk that hasn’t bitten yet (limited impact so far). The RQ may be flat to slightly soft, and price may be unreactive—no realized shock yet.